Filings (90d)
Other insiders active in the same sector
No other insider has filed at Barry Fishman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- Robert M. Williams Jr. - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barry Fishman?
Barry Fishman is a corporate insider, tracked as Director of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Barry Fishman last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 3 filings going back to 2025.